CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 100 of 276 entries

View as:

Breastfeeding, Antiretroviral, and Nutrition Study

Phase: N/A Priority: Normal

NCT ID: NCT00164736 Org: User:

Start: 03/31/04 End: 01/31/10 Due: 01/31/11

Linezolid Pharmacokinetics (PK) in Multi-Drug Resistant (MDR)/Extensively-Drug Resistant (XDR) Tuberculosis (TB)

Phase: N/A Priority: Normal

NCT ID: NCT00691392 Org: User:

Start: 04/30/09 End: 05/31/10 Due: 05/31/11

Treatment and Diagnosis of Plague

Phase: N/A Priority: Normal

NCT ID: NCT00128466 Org: User:

Start: 08/31/04 End: 02/28/07 Due: 02/28/08

In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria

Phase: N/A Priority: Normal

NCT ID: NCT02637128 Org: User:

Start: 03/31/14 End: 07/31/14 Due: 07/31/15

NHANES Urinary Sodium Calibration Study

Phase: N/A Priority: Normal

NCT ID: NCT01631240 Org: User:

Start: 06/30/11 End: 08/31/11 Due: 08/31/12

Intermittent Preventive Treatment With Antimalarials in Kenyan Infants

Phase: N/A Priority: Normal

NCT ID: NCT00111163 Org: User:

Start: 03/31/04 End: 03/31/08 Due: 03/31/09

Safety Study of UC-781 Vaginal Microbicide

Phase: N/A Priority: Normal

NCT ID: NCT00446979 Org: User:

Start: 06/30/07 End: 10/31/07 Due: 10/31/08

High Dose Rifapentine Pharmacokinetics, Tolerability and Safety Dosage Rifapentine for Treatment of Tuberculosis

Phase: N/A Priority: Normal

NCT ID: NCT01043575 Org: User:

Start: 04/30/09 End: 05/31/10 Due: 05/31/11

TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection

Phase: N/A Priority: Normal

NCT ID: NCT00164450 Org: User:

Start: 09/30/05 End: 08/31/08 Due: 08/31/09

Evaluation of Insecticide Treated Nets and Wall Liners for the Prevention of Malaria

Phase: N/A Priority: Normal

NCT ID: NCT01043796 Org: User:

Start: 05/31/10 End: 12/31/14 Due: 12/31/15

Chlorproguanil-Dapsone in Pregnant Women

Phase: N/A Priority: Normal

NCT ID: NCT00126971 Org: User:

Start: 07/31/05 End: - Due: -

Multi-site Study of Rapid Diagnostic Syphilis Assays

Phase: N/A Priority: Normal

NCT ID: NCT00300534 Org: User:

Start: 08/31/02 End: 07/31/09 Due: 07/31/10

Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women

Phase: N/A Priority: Normal

NCT ID: NCT00362375 Org: User:

Start: 05/31/06 End: 04/30/08 Due: 04/30/09

Adherence to Lumefantrine-Artemether

Phase: N/A Priority: Normal

NCT ID: NCT00153491 Org: User:

Start: 08/31/02 End: 08/31/06 Due: 08/31/07

A Trial on the Effect of Sino-implant (II) Use on Condom Use Among Women in Kingston, Jamaica

Phase: N/A Priority: Normal

NCT ID: NCT01684358 Org: User:

Start: 09/30/12 End: 02/28/14 Due: 02/28/15

Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting

Phase: N/A Priority: Normal

NCT ID: NCT00207584 Org: User:

Start: 01/31/94 End: 04/30/94 Due: 04/30/95

Video-based Intervention Study to Prevent HIV/Sexually Transmitted Diseases (STDs) Among STD Clinic Patients

Phase: N/A Priority: Normal

NCT ID: NCT00137670 Org: User:

Start: 04/30/02 End: 03/31/09 Due: 03/31/10

Open Label Extension (OLE) of the TDF2 Study, Botswana

Phase: N/A Priority: Normal

NCT ID: NCT04318210 Org: User:

Start: 10/31/12 End: 07/31/14 Due: 07/31/15

Racial Disparities in Pneumococcal Vaccination in Managed Care

Phase: N/A Priority: Normal

NCT ID: NCT00229762 Org: User:

Start: 03/31/04 End: 06/30/05 Due: 06/30/06

JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo

Phase: N/A Priority: Normal

NCT ID: NCT02977715 Org: User:

Start: 02/23/17 End: 12/31/25 Due: 12/31/26

Ke Ala Lokahi Demonstration Project for Sexual and Domestic Violence Prevention

Phase: N/A Priority: Normal

NCT ID: NCT00164268 Org: User:

Start: 10/31/02 End: 08/31/05 Due: 08/31/06

Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections

Phase: N/A Priority: Normal

NCT ID: NCT00207753 Org: User:

Start: 02/28/05 End: 03/31/05 Due: 03/31/06

Diarrhea and Bivalent Oral Polio Vaccine Immunity

Phase: N/A Priority: Normal

NCT ID: NCT01559636 Org: User:

Start: 08/31/12 End: 10/31/13 Due: 10/31/14

An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment

Phase: N/A Priority: Normal

NCT ID: NCT03266003 Org: User:

Start: 07/19/17 End: 12/31/20 Due: 12/31/21

Research to Improve Smoke Alarm Functioning and Maintenance

Phase: N/A Priority: Normal

NCT ID: NCT00139126 Org: User:

Start: 08/31/05 End: - Due: -

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Breastfeeding, Antiretroviral, and Nutrition Study	NCT00164736	Centers for Disease Control and Prevention	user2@example.com	None	2004-03-31	2010-01-31	2011-01-31	-	-	2025-07-14
Linezolid Pharmacokinetics (PK) in Multi-Drug Resistant (MDR)/Extensively-Drug Resistant (XDR) Tuberculosis (TB)	NCT00691392	Centers for Disease Control and Prevention	user2@example.com	None	2009-04-30	2010-05-31	2011-05-31	-	-	2025-07-14
Treatment and Diagnosis of Plague	NCT00128466	Centers for Disease Control and Prevention	user2@example.com	None	2004-08-31	2007-02-28	2008-02-28	-	-	2025-07-14
In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria	NCT02637128	Centers for Disease Control and Prevention	user2@example.com	None	2014-03-31	2014-07-31	2015-07-31	-	-	2025-07-14
NHANES Urinary Sodium Calibration Study	NCT01631240	Centers for Disease Control and Prevention	user2@example.com	None	2011-06-30	2011-08-31	2012-08-31	-	-	2025-07-14
Intermittent Preventive Treatment With Antimalarials in Kenyan Infants	NCT00111163	Centers for Disease Control and Prevention	user2@example.com	None	2004-03-31	2008-03-31	2009-03-31	-	-	2025-07-14
Safety Study of UC-781 Vaginal Microbicide	NCT00446979	Centers for Disease Control and Prevention	user2@example.com	None	2007-06-30	2007-10-31	2008-10-31	-	-	2025-07-14
High Dose Rifapentine Pharmacokinetics, Tolerability and Safety Dosage Rifapentine for Treatment of Tuberculosis	NCT01043575	Centers for Disease Control and Prevention	user2@example.com	None	2009-04-30	2010-05-31	2011-05-31	-	-	2025-07-14
TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection	NCT00164450	Centers for Disease Control and Prevention	user2@example.com	None	2005-09-30	2008-08-31	2009-08-31	-	-	2025-07-14
Evaluation of Insecticide Treated Nets and Wall Liners for the Prevention of Malaria	NCT01043796	Centers for Disease Control and Prevention	user2@example.com	None	2010-05-31	2014-12-31	2015-12-31	-	-	2025-07-14
Chlorproguanil-Dapsone in Pregnant Women	NCT00126971	Centers for Disease Control and Prevention	user2@example.com	None	2005-07-31	-	-	-	-	2025-07-14
Multi-site Study of Rapid Diagnostic Syphilis Assays	NCT00300534	Centers for Disease Control and Prevention	user2@example.com	None	2002-08-31	2009-07-31	2010-07-31	-	-	2025-07-14
Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women	NCT00362375	Centers for Disease Control and Prevention	user2@example.com	None	2006-05-31	2008-04-30	2009-04-30	-	-	2025-07-14
Adherence to Lumefantrine-Artemether	NCT00153491	Centers for Disease Control and Prevention	user2@example.com	None	2002-08-31	2006-08-31	2007-08-31	-	-	2025-07-14
A Trial on the Effect of Sino-implant (II) Use on Condom Use Among Women in Kingston, Jamaica	NCT01684358	Centers for Disease Control and Prevention	user2@example.com	None	2012-09-30	2014-02-28	2015-02-28	-	-	2025-07-14
Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting	NCT00207584	Centers for Disease Control and Prevention	user2@example.com	None	1994-01-31	1994-04-30	1995-04-30	-	-	2025-07-14
Video-based Intervention Study to Prevent HIV/Sexually Transmitted Diseases (STDs) Among STD Clinic Patients	NCT00137670	Centers for Disease Control and Prevention	user2@example.com	None	2002-04-30	2009-03-31	2010-03-31	-	-	2025-07-14
Open Label Extension (OLE) of the TDF2 Study, Botswana	NCT04318210	Centers for Disease Control and Prevention	user2@example.com	None	2012-10-31	2014-07-31	2015-07-31	-	-	2025-07-14
Racial Disparities in Pneumococcal Vaccination in Managed Care	NCT00229762	Centers for Disease Control and Prevention	user2@example.com	None	2004-03-31	2005-06-30	2006-06-30	-	-	2025-07-14
JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo	NCT02977715	Centers for Disease Control and Prevention	user2@example.com	None	2017-02-23	2025-12-31	2026-12-31	-	-	2025-07-14
Ke Ala Lokahi Demonstration Project for Sexual and Domestic Violence Prevention	NCT00164268	Centers for Disease Control and Prevention	user2@example.com	None	2002-10-31	2005-08-31	2006-08-31	-	-	2025-07-14
Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections	NCT00207753	Centers for Disease Control and Prevention	user2@example.com	None	2005-02-28	2005-03-31	2006-03-31	-	-	2025-07-14
Diarrhea and Bivalent Oral Polio Vaccine Immunity	NCT01559636	Centers for Disease Control and Prevention	user2@example.com	None	2012-08-31	2013-10-31	2014-10-31	-	-	2025-07-14
An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment	NCT03266003	Centers for Disease Control and Prevention	user2@example.com	None	2017-07-19	2020-12-31	2021-12-31	-	-	2025-07-14
Research to Improve Smoke Alarm Functioning and Maintenance	NCT00139126	Centers for Disease Control and Prevention	user2@example.com	None	2005-08-31	-	-	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance